[HTML][HTML] Role of red blood cells in clinically relevant bleeding tendencies and complications
The multiple roles of red blood cells (RBCs) are often neglected as contributors in
hemostasis and thrombosis. Proactive opportunities to increase RBC numbers, either …
hemostasis and thrombosis. Proactive opportunities to increase RBC numbers, either …
Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities
Z Gou, D Zhang, H Cao, Y Li, Y Li, Z Zhao… - Frontiers in Cell and …, 2024 - frontiersin.org
The myosin heavy chain 9 (MYH9) gene, located on human chromosome 22, encodes non-
muscle myosin heavy chain IIA (NM IIA). This protein is essential to various cellular events …
muscle myosin heavy chain IIA (NM IIA). This protein is essential to various cellular events …
Leveraging a neutrophil-derived PCD signature to predict and stratify patients with acute myocardial infarction: from AI prediction to biological interpretation
Y Zhu, Y Chen, Y Zu - Journal of translational medicine, 2024 - Springer
Background Programmed cell death (PCD) has recently been implicated in modulating the
removal of neutrophils recruited in acute myocardial infarction (AMI). Nonetheless, the …
removal of neutrophils recruited in acute myocardial infarction (AMI). Nonetheless, the …
Megakaryocyte-induced contraction of plasma clots: cellular mechanisms and structural mechanobiology
OV Kim, RI Litvinov, AL Gagne, DL French, LF Brass… - Blood, 2024 - ashpublications.org
Nonmuscle cell contractility is an essential feature underlying diverse cellular processes
such as motility, morphogenesis, division and genome replication, intracellular transport …
such as motility, morphogenesis, division and genome replication, intracellular transport …
A novel technique to quantify the kinetics of blood clot contraction based on the expulsion of fluorescently labeled albumin into serum
Background The platelet-driven contraction or retraction of blood clots has been utilized to
obtain blood serum for laboratory studies, but now, in vitro clot contraction assays are used …
obtain blood serum for laboratory studies, but now, in vitro clot contraction assays are used …
MYH9基因突变伴肾小球轻微病变一例
靳远萌， 张春丽， 徐静， 谢静远 - 罕见病研究, 2024 - jrd.chard.org.cn
MYH9 突变相关性疾病是一种常染色体显性疾病, 发病机制为编码非肌肉肌球蛋白重链ⅡA
的MYH9 基因突变导致细胞内肌球蛋白异常聚集, 进而引起血液系统, 眼, 耳, 肾脏 …
的MYH9 基因突变导致细胞内肌球蛋白异常聚集, 进而引起血液系统, 眼, 耳, 肾脏 …
[引用][C] Identification of a novel MYH9‐related disease‐associated mutation with multiple faintly staining Döhle‐like bodies
C Yin, E Turley, J Livingston - Pediatric Blood & Cancer, 2024 - Wiley Online Library